AXIM® Biotechnologies Begins Clinical Trials on Its ImmunoPass Rapid Diagnostic Test With Vaccine Recipients

NEXT STORY
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan
PREV STORY
Telo Genomics Retains Former Abbott & Siemens Veteran Gregg Mayer to Lead the Development of the Company’s Industry Partnership Strategy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunicum AB (publ) Announces Completion of Patient Recruitment for Phase Ib Portion of ILIAD Combination Clinical Trial

author_avatar
NASDAQ Market News

Global Sepsis Therapeutics Market Analysis, Trends, and Forecasts, 2018-2024: GIAPREZA – The Only FDA Approved Branded Drug for Sepsis Treatment

Dublin, Feb. 07, 2019 (GLOBE NEWSWIRE) -- The "Sepsis Therapeutics - Market Analysis, Trends, ...

author_avatar
NASDAQ Market News

Ikena Oncology to Participate in September 2021 Virtual Investor Conferences

author_avatar
NASDAQ Market News